---
created: 2025-04-13
updated: 2025-04-13T10:51
id: i`WsIu@-yd
specialty: endo
specialty_id: 81
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::04-g-protein-linked-second-messengers::vasopressin::v2
  - source/ak-step1-v11::
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs
  - source/ak-step1-v11::
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs::*adh-physiology
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::14-endocrine
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::07-endocrine::13-adh-related-drugs
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::01-general::v2-(vasopressin)-receptors
  - source/ak-step1-v11::
  - theme/sketchypharm::05-gi-&-endocrine::04-hypothalamic-&-pituitary::02-adh,-ddavp,-adh-receptor-antagonists
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::endocrine::pharmacology"
type: flashcard
---

# Question
ADH activation of the **V2** receptor on vascular endothelium causes release of **von Willebrand factor (vWF)** and **factor VIII**

---

# Answer
